In a report published Friday, Edison Investment Research analyst Bridie Barrett Schmidt initiated coverage on Emulex ELX, but did not assign a rating or price target.
In the report, Edison Investment Research noted, “Emulex's longer-term prospects should become clearer as visibility on its ability to reinstate its position in 10gE and leverage synergies from Endace become apparent. With only modest revenue growth forecast, the $30m cost savings and the $200m share repurchase programme should drive strong earnings growth into 2015. This should support the shares' value on the downside, and evidence of successful execution of its strategy could see 10-20% rating upside and could drive significant earnings upgrades.”
Emulex closed on Thursday at $6.81.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in